UBS Faces $37 Billion Capital Hit from Swiss Regulatory Changes, Calls Proposals 'Extreme'

summarizeSummary

UBS Group AG announced that new Swiss regulatory capital requirements, including those related to foreign participations and asset valuation, are expected to necessitate an additional $37 billion in CET1 capital and incur $3 billion in annual costs, which the bank strongly opposes.

check_boxKey Events

• New Capital Adequacy Ordinance (CAO)

  The Swiss Federal Council finalized a new CAO, expected to eliminate approximately $4 billion of net CET1 capital at the Group level by 2029 due to changes in capitalized software amortization and prudential valuation adjustments.

• Foreign Participation Proposal

  A proposal submitted to parliament would require full deduction of foreign participations from UBS AG's standalone CET1 capital, estimated to demand an additional $20 billion in CET1 capital, phased in over seven years.

• Total Capital Impact

  Combined with existing Credit Suisse acquisition requirements, UBS expects to need around $37 billion in total additional CET1 capital, incurring an annual cost of approximately $3 billion.

• UBS's Strong Disagreement

  UBS 'strongly disagrees' with the proposed package, calling it 'extreme' and warning of 'far-reaching consequences for the Swiss economy,' and will provide further comments with Q1 2026 results.

auto_awesomeAnalysis

This filing reveals a significant regulatory challenge for UBS Group AG, with new Swiss capital requirements expected to demand an additional $37 billion in CET1 capital and incur an annual cost of approximately $3 billion. The magnitude of this capital increase, representing a substantial portion of the company's market capitalization, is a critical development. UBS's strong opposition, labeling the proposals as 'extreme' and warning of 'far-reaching consequences for the Swiss economy,' underscores the severity of the situation. While the company maintains its 2026 financial targets and capital return plans, as the changes are not fully effective until 2027, investors should closely monitor the parliamentary deliberations on foreign participations and UBS's Q1 2026 results for further commentary and potential mitigation strategies.